VC fund profile · evidence-aware directory data

Mountain Group Partners stages, portfolio and investment profile

Nashville early-stage venture firm founded in 2002, investing in life sciences, AgTech, and disruptive technology. Hands-on operator model with investments across 60+ companies historically (firm materials). Targets seed and early venture in medical devices, diagnostics, animal health/agriculture tech, and healthcare/business technology.

Keep track of Mountain Group Partners

Save this profile to your VCT watchlist for a quick return.

View watchlist

Stage-based planning range

$1M–$10M

This is a planning range inferred from stage coverage, not a firm-disclosed check size.

Methodology: Stage bucket inferred from the rounds a fund leads or invests in.

No firm-specific check-size disclosure is recorded.

Source link not recorded Confidence: 25% Verified: Not recorded View methodology

Investment stages

Leads: Seed, Series A

Participates: Seed, Series A, Series B

Sector focus

Biotech & Life Sciences · Healthtech · Climate Tech · Deep Tech

Geography

Nashville, TN

Founded 2002

Fund size / AUM

Multi-fund early-stage (verify ADV)

A separate fund-size evidence record is not yet available.

Portfolio in our directory

None yet

Linked startup profiles

Latest fund vehicle

Not recorded

Vehicle name, size, and vintage are not yet structured.

Recent tracked investment

Not recorded

No dated round explicitly links this fund.

Rounds they lead

Seed Series A

Rounds they invest

Seed Series A Series B

Last verified: Not recorded. Check-size evidence is labeled by basis so planning estimates are not presented as firm disclosures.

FAQs about Mountain Group Partners

Stage fit, check size, thesis, and how founders typically approach this firm — based on public sources and our directory.

Nashville, Tennessee.

2002.

Seed and early-stage venture (Series A/B participation common); confirm current fund parameters with the firm.

Life sciences (devices, diagnostics, opportunistic therapeutics), AgTech/animal health, and disruptive technology per mtngp.com.

Often an active early institutional investor; lead vs. participate varies deal-by-deal.

Via mtngp.com and warm intros from Middle Tennessee life-sciences/AgTech operators.

U.S. early-stage with strong Nashville / Southeast network.

Operator-backed investing in underserved niches within life sciences and AgTech rather than coastal consumer SaaS.

Website LinkedIn

By Venture Capital Tracker

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.